Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$MRVI Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.08 up 70.37% YoY • Reported revenue of $51.44M up 8.53% YoY • Maravai LifeSciences maintains its 2026 revenue guidance range of $205.0 million to $215.0 million and raised its full year 2026 Adjusted EBITDA guidance to $33.0 million to $35.0 million.

Price since post

Full Details

Advertisement|Remove ads.